MarketInOut Stock Screener Log In | Sign Up

AstraZeneca Plc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 11/03/2026 16:00
AstraZeneca Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization289,477 mln
Float1,498 mln
Earnings Date10/30/2026

EPS

6.69
Strong

P / E

27.49
Elevated

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.51
Likely reliable

1-Year Forecast

206.66
Modest upside

Relative Strength

94 / 100
Top performer

Business Description

AstraZeneca is a British pharmaceutical company headquartered in Cambridge, UK, that researches, develops, and sells prescription medicines worldwide. Its treatments span a wide range of serious health conditions, including cancer, heart and kidney disease, diabetes, respiratory illness, and rare genetic disorders, and it also produces vaccines and immune therapies. The company sells its products through distributors and local sales teams across Europe, the Americas, Asia, Africa, and Australasia, serving both general practitioners and specialist physicians. Originally formed through a merger and known as Zeneca Group PLC, AstraZeneca has operated under its current name since 1999 and continues to expand its research capabilities through partnerships with technology and biotechnology firms.

Key Fundamentals

EPS6.69
P/E27.49
ROE22.04
RPS40.25
ROIC12.34
ROA9.15
Interest Cover7.86
EBITDA, mln21,541
EV / EBITDA14.55
EV / EBIT21.00
Revenue, mln62,384
EV / Revenue4.91

Quote Details

Last 183.88
Change -2.7 (-1.45%)
Open 186.11
Volume 3,682,101
Turnover 677,064,768
Average Volume 3,007,516

Financial Ratios

Pre-Tax Profit Margin21
Leverage Ratio2.32
Current Ratio0.89
Price / Book5.71
Price / Cash Flow21.70
Price / Free Cash Flow26.72
Debt / Equity0.64
Price / Sales4.77
PEG Ratio1.14

Financial Strength

Altman Z-Score3.51
Piotroski F-Score 8 / 9
Beneish M-Score-2.51
Price to Intrinsic Value1.67
Price to Lynch Fair Value1.17
1-Year Target Price206.66
Shiller PE Ratio50.70
Short Ratio1.14
Short % of Float0.21

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.11% 95 / 100   
1 Month 17.47% 96 / 100   
2 Months 6.8% 85 / 100   
6 Months 2.12% 60 / 100   
1 Year 14.68% 68 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog